OSCE Drugs Flashcards

1
Q
Aluminium  Hydroxide? (Maalox)
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Antacid
Mechanism of action - Neutralises HCl in gastric secretions to form AlCl and water. Also inhibits action of pepsin by increasing pH.
Indication - Dyspepsia
Pharmacokinetics - 17-30% if absorbed. Rapidly eliminated by the kidneys.
ADR’s: Constipation, hyperalbuminaemia, avoid in hepatic and renal impairment.
Contraindications - hypophosphatemia, infants, neonates
DDI’s - ACE Inhibitors, Aspirin, Certain antibiotics, Bisphosphonates, Digoxin, Folate acid, etc…Can be avoided by not taking at same time as other drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
Gaviscon (Compound Alginate)
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Antacids - alginate
Mechanism of action - Raft antacid
Indication - Dyspepsia
Pharmacokinetics
ADR’s - Nausea, constipation, diarrhoea, headache
Contraindications - Intestinal Obstruction, Preterm neonates, or where excessive fluid loss is likely.
DDI’s - Most drugs - don’t take them at the same time. Some risk of hyperkalaemia which certain drugs e.g. ACE inhibitors, Cyclosporine. May damage enteric coating designed to prevent dissolution in the stomach. Not to be used with thickening agents.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
Hyoscine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Ach antagonist - anti-spasmodic, Anti-emetic
Mechanism of action - Direct antagonist of muscarinic cholinergic receptors
Indication - Motion Sickness
Pharmacokinetics - Oral or patch - effects usually last 12 hours, bioavailability 10-50%. Half Life 4.5 hours. Excreted poorly by kidney.
ADR’s - dry mouth, urine retention, constipation, loss of accommodation - photophobia, skin dryness/flushing, transient bradycardia, urinary urgency.
Contraindications - GI obstruction, Intestinal atony, Myasthenia gravis, paralytic ileus, severe UC, pyloric stenosis, bladder outflow obstruction, urinary retention. Acute MI, tachycardia, diarrhoea, elderly, GORD
DDI’s -other anti-muscarinic agents - increased side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
Mebeverine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Anti-spasmodic
Mechanism of action - synthetic anti-cholinergic - direct action on smooth muscle of GI tract.
Indication - Releive colicky like pain associated with IBS
Pharmacokinetics - rapidly and completely absorbed. Metabolised completely.
ADR’s - allergic reaction - angioedema, rash, urticaria
Contraindications - paralytic ileus
DDI’s- ???

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
Ranitidine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - H2 Antagonist
Mechanism of action - Antagonist of H2 receptor on parietal cells - prevents release of protons.
Indication - Dyspepsia, H. Pylori infection, GORD, Peptic ulcer disease
Pharmacokinetics - 50% bioavailability, hepatic metabolism, excretion in urine.
ADR’s -Diarrhoea, dizziness, headache, (rare - cholestatic jaundice, bradycardia, psychiatric symptoms, thrombocytopenia)
Contraindications -
DDI’s - Histamine, absorption of a select number of drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
Omeprazole, Lansoprazole, esomeprazole
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Proton Pump Inhibitors
Mechanism of action - Antagonise PPI on parietal cells to reduce acid secretion.
Indication - Dyspepsia, H. Pylori Infection, GORD, Peptic ulcer disease
Pharmacokinetics - prodrug which is converted to active form in acid environment of the stomach. Has no effect elsewhere in the body
ADR’s - risk of SLE, abdo pain, constipation, diarrhoeas, flatulence, GI disturbances, headache, nausea and vomiting
Contraindications
DDI’s - Lots affects plasma concentrations.
Monitoring - measurement of serum Mg before and during prolonged PPI treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
Loperamide
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Anti-motility
Mechanism of action - opioid receptor agonist acting on Mu receptor in the mesenteric plexus, does not affect CNS. Prolongs transit time of intestinal contents, reduces daily faecal volume, increases viscosity and bulk density.
Indication - Acute and chronic diarrhoea, Faecal incontinence,
Pharmacokinetics - No significantly absorbed from the gut. Hepatic metabolism and excretion of unchanged loperamide and metabolites is via faeces.
ADR’s - dizziness, flatulence, headache, nausea. Rare - paralytic ileus, Steven-Johnson syndrome.
Contraindications - Acute UC, antibiotic associated colitis, abdominal distension
DDI’s - Desmopressin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
Ispaghula (Husk)
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Bulk Laxative
Mechanism of action - Increases the insoluble fibre in the gut, this helps to form solid faeces which distends the gut which activates the stretch receptors and increase gut motility.
Indication - Constipation
Pharmacokinetics - Not absorbed by body, excreted via faeces.
ADR’s - Flatulence, abdominal distension, GI impaction, GI obstruction, hypersensitivity
Contraindications - GI adhesions/ulcerations - May cause intestinal obstruction, Difficulty swallowing.
DDI’s - may delay GI absorption of certain drugs/vitamins and minerals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
Senna
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Stimulant Laxative
Mechanism of action - converted by bacteria in the intestine to active form. Stimulated motility, inhibition of water and electrolyte absorption.
Indication - Constipation
Pharmacokinetics - Onset 8-12 hours, excreted in faeces.
ADR’s - Abdominal cramp
Contraindications - Intestinal Obstruction
DDI’s - Can get hypokalaemia with long term abuse or with other drugs that induce hypokalaemia e.g. diuretics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
Lactulose
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Osmotic Laxative
Mechanism of action - Lactulose is broken down into lactic acid in gut. This increases osmotic pressure and slightly acidifies colonic contents. This increases stool water content and softens stool. (Draws out ammonia in hepatic encephalopathy)
Indication - Constipation (hepatic encephalopathy)
Pharmacokinetics - can take up to 48 hours to act. No absorbed from GI tract. Faecal elimination.
ADR’s - Abdominal discomfort, cramps, flatulence, nausea, vomiting.
Contraindications - Galactosamia, intestinal obstruction, lactose intolerance
DDI’s - Coumarins (anticoagulant) - enhanced effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
Movicol
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Macrogols - osmotic laxative
Mechanism of action - Increased stool volume which triggers colon motility via neuromuscular pathwyas.
Indication - Constipation, faecal impaction
Pharmacokinetics - 2-4 days to get full relief. Eliminated in faeces not absorbed.
ADR’s - Abdominal distension, abdominal pain, flatulence, nausea
Contraindications - Intestinal obstruction, crohns disease, intestinal perforation, paralytic ileus, toxic megacolon, UC.
DDI’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
Glycerol Suppositories
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Irritant Laxative
Mechanism of action - promotes peristalsis and evacuation of the lower bowl
Indication - Constipation
Pharmacokinetics - Suppository
ADR’s - Can cause irritation and abdominal cramps
Contraindications - hypersensitivity to glycerol
DDI’s - none known

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
Phosphate enemas
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Bulk Laxative
Mechanism of action - Increased fluid accumulation in the lower bowel produces distension and promotes peristalsis and bowel movement by activating stretch receptors.
Indication - Constipation, Bowel evacuation before abdominal radiological, endoscopy, surgical procedures.
Pharmacokinetics - absorption minimal - can get hyperphosphataemia though.
ADR’s - Abdominal distensions, abdominal pain, nausea, vomiting, dehydration, dizziness, headache (can cause electrolyte disturbances, arrhythmias, renal failure)
Contraindications - with Oral use - acute severe colitis, ascites, congestive heart failure, GI obstruction, GI perforation, toxic mega colon. By rectal route: conditions association with increased colonic absorption, GI obstruction, inflammatory bowel disease.
DDI’s - Other oral drugs should be taken one hour before or after administration of phosphate enema.
Monitoring - Assess renal function in patients at risk of fluid and electrolyte disturbances.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
Mesalazine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - DMARD - sulphasalazine
Mechanism of action - Inhibits proliferation of T cells by causing T cell apoptosis. This inhibits interleukin 2 production and reduced chemotaxis and degranulation of neutrophils.
Indication - Irritable Bowel Disease - acute attacks and remission
Pharmacokinetics - Metabolised in the gut. Poorly absorbed as main action is within the intestine.
ADR’s - Myelosupression, hepatitis, rash, blood disorders, lupus, Stevens-Johnson syndrome, exacerbation of symptoms of colitis.
Contraindications - Hepatic impairment, monitoring required in renal disease
DDI’s - Preparations that lower stool pH e.g. Lactulose - may prevent release of mesalazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
Infliximab
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - DMARD - anti-TNF agent
Mechanism of action - An anti-human tumour necrosis factor monoclonal antibody. Binds to TNF-alpha and its receptors. This which reduces inflammation by decreasing the cytokine cascade and therefore recruitment of leukocytes to the area.
Indication - IBD, RA (with methotrexate), Ankylosing spondylitis, Psoriatic arthritis (with methotrexate) Plaque psoriasis.
Pharmacokinetics - Onset of action occurs in about 2 weeks in crohn’s. Removed by opsonisation via the reticulo-endothelial system.Half life 9.5 days.
ADR’s - Increased risk of malignancy in those who have has previous malignancy, risk of serious infections, skin/soft tissue infections. TB reactivation
Contraindications - Moderate or severe heart failure, severe infections.
DDI’s - Vaccines Clozapine, Abatacept, Anakinra
Should screen for TB before starting treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
Digoxin
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Cardiac Glycoside
Mechanism of action - Blocks the Na+/K+ ATPase exchanger in the myocardium. This causes Na+ to accumulate within the cell and reverses the Na+/Ca2+ exchanger. Ca2+ accumulates in the cell which may promote the activation of contractile proteins.
Indication - Heart Failure, AF,
Pharmacokinetics - Needs a loading dose - 3-5 day half life. Hepatic metabolism but doesn’t depend on CYP. Excreted mainly unchanged in urine.
ADR’s - Arrhythmias, blurred vision, conduction disturbances, diarrhoea, dizziness, oosinophilia, nausea, rash, vomiting, yellow vision.
Contraindications - Constrictive pericarditis, hypertrophic cardiomyopathy, intermittent heart block, second degree AV block,
DDI’s - Acetazolamide, Amphotericin, Beta blockers, calcium salts, Colestipol, Colestryamine, Corticosteroids, Diuretics - loop and thiazide, NSAIDS, Sucralfate, Suxamethonium, Tizanidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
Bendroflumethiazide
Indapamide
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Diuretic
Mechanism of action - Acts on the Na+/Cl- Co transporter in the distal tubule to prevent Na+ reabsorption which in turn prevents water reabsorption.
Indication - Hypertension, Oedema
Pharmacokinetics
ADR’s - Altered plasma lipid concentrations, gout, hypercalcamia, glycaemia, uricaemia. Hypokalameia, -magnesaemia, -natraemia. Postural hypotension.
Contraindications - Addison’s, hypercalcaemia, hyponatraemia, refractory hypokalaemia, symptomatic hyperuricaemia. Avoid in sever live disease.
DDI’s - amiodarone, Amphotericin, Antidiabetics, Calcitriol, Ciclosporin, Colecalciferol, Colestryamine, Corticosteroids, Loop Diuretics, Flecainide, Lidocaine, Lithium, Beta 2 sympathomimetics, Vit D.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
Furosemide
Bumetanide
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Loop Diuretic
Mechanism of action - Inhibit reabsorption from the ascending limb of loop of Henle by blocking the sodium-potassium-chloride cotransporter.
Indication - Oedema (Heart Failure/Liver disease/Renal Disease), Resistant Hypertension.
Pharmacokinetics - 60% absorbed, excreted in the urine, half life of 2 hours.
ADR’s - Ototoxic, Hyponatremia, postural hypertension, electrolyte disturbances, gout, Hypokalaemia. Myelosupression.
Contraindications -Anuria, Comatose and Pre-comatose states related with liver cirrhosis, renal failure due to nephrotoxic/hepatotoxic drugs. Sever Hypokalaemia, severe hyponatremia.
DDI’s - Phenytoin, Aminoglycosides, Amiodarone, Amphotericin, Anti-diabetics, Aspirin, cardiac glycosides, Corticosteroids, Flecanide, lidocaine, lithium, polymixins, sympathomimetics beta 2. Vancomycin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
Amiloride
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Diuretic
Mechanism of action - Inhibits ENaC channels in DCT/CD - K+ sparing. Block Na+ transport channels.
Indication - oedema, potassium conservation when used with thiazide/loop diuretics
Pharmacokinetics - Not metabolised by the liver but excreted unchanged by the kidneys. Half life 6-9 hours.
ADR’s - Abdo. pain, agitation, arrhythmias, encephalopathy, GI bleeding, Jaundice, Postural hypotension, raised intra ocular pressure,
Contraindications - Addison’s, anuria, hyperkalaemia.
DDI’s - ACE inhibitors, ARB Antagonists, Cyclosporine, Lithium, NSAIDS, Potassium salts, Tacrolimus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
Spironolactone
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Potassium Sparing Diuretics - Aldosterone antagonist.
Mechanism of action - Acts on aldosterone receptors and blocks the action of aldosterone. Prevents expression of ENac, K+ and Na+/K+ ATPase channels. This prevents the reabsorption of Na+ in the distal tubule and collecting trunks.
Indication - Oedema, Nephrotic Syndrome, Resistant hypertension, Conn’s syndrome. Can be used in combination with thiazide or loop diuretic to reduce K+ excretion.
Pharmacokinetics - completely absorbed orally and strongly bound to proteins. Induces hepatic CYP450.
ADR’s - gastric upsets, peptic ulcers, gynaecomastia in male patients and menstrual abnormalities in females. Hyperkalaemia, nausea, lethargy and mental confusion.
Contraindications - Addison’s anuria, hyperkalaemia
DDI’s - Potassium supplements, ACE Inhibitor, ARB antagonist, Aspirin, Digoxin, Trimethoprim

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q
Adenosine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Anti-Arrhythmic
Mechanism of action - slows AV conduction and can interrupt re-entry pathways through AV node. It is an endogenous nucleoside and activates cell surface A1 and A2 adenosine receptors. Vasodilation of smooth muscle.
Indication - Rapid reversal of Supraventricular tachycardia, stress test radionuclide myocardial imaging.
Pharmacokinetics - rapidly metabolised by phosphorylation or deamination. Half life is less than 10 seconds.
ADR’s - angina, apprehension, arrhythmia, AV block, dizziness, dyspnoea, flushing, headache, nausea, sinus pause.
Contraindications - Asthma, COPD, decompensated heart failure, long QT, 2nd/3rd degree heart block, sick sinus syndrome, severe hypotension.
DDI’s - Aminophylline (Diuretic) caffeine citrate, Dipyridamole (anti-platelet) Nicotine, Theophylline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q
Amiodarone
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Class III antiarrhythmic
Mechanism of action - K+ channel blockers - prolongation of phase 3 of the action potential. Increases refractory period and slows down intra-cardiac conduction. Relaxation of vascular smooth muscle - reduction of afterload.
Indication - Ventricular and supraventricular arrhythmias. VF
Pharmacokinetics - Long half life
ADR’s - Bradycardia, jaundice, Pulmonary fibrosis, Hepatic Injury, Increased LDL Cholesterol, Hypo and hyperthyroidism, Photosensitivity
Contraindications - Severe conduction disturbances, SA heart block, sinus bradycardia, thyroid dysfunction
DDI’s - EVERYTHING - Tricyclic antidepressants, Beta blockers, Cimetidine, Coumarins, Citalopram, Digoxin, Loop and thiazide diuretics etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q
Flecanide 
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - IC antiarrhythmic
Mechanism of action - Blocks Na+ channels when they are in the active position which prevents after-depolarisations.
Indication - SVT, paroxysmal AF, Ventricular arrhythmias
Pharmacokinetics - Nearly complete oral absorption, Hepatic metabolisms, urinary excretion
ADR’s - Asthenia, dizziness, dyspnoea, fatigue, fever, oedema, pro-arrhythmic effects, visual disturbances
Contraindications - Abnormal left ventricular function, atrial conduction defect, bundle branch block, Valvular disease, heart disease, MI,
DDI’s - Amiodarone, Tricyclic antidepressants, Beta blockers, Cimetidine, Thiazide and Loop Diuretics, Fluoxetine, Verapamil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q
Lidocaine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class- IB Antiarrhythmic
Mechanism of action - Na+ channel blocker -stimulation threshold during diastole raised. Fast Na+ channels inactivated so more difficult to initiate AP.
Indication - Antiarrhythmic, local anaesthetic/regional block, CPR (if no Amiodarone available)
Pharmacokinetics - Completely absorbed following parental administration. Hepatic metabolism. Excreted by the kidney.
ADR’s - Bradycardia, confusion, dizziness, drowsiness, paraesthesia, resp. depression. confusion, hypotension, anaphylaxis. Can be avoided with topical administration.
Contraindications - AV block, Myocardial depression, SA disorders, No preparations with preservative for caudal, epidural or spinal block.
DDI’s - cimetidine, HIV drugs, Loop and thiazide diuretics, propranolol,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Atenolol
Bisoprolol
Propanolol
Sotalol

A

Class - Beta Blockers
Mechanism of action - Antagonist of the Beta 1 Receptors in the SA and AV node. Prevention of Activation of Gs GPCR protein results in less Ca2+ entry so decreased force of contraction. Reduced HR.
Indication - Hypertension, Angina, Heart Failure, prevention of MI, arrhythmias
Pharmacokinetics - Vary depend on drug. Hepatic metabolism. Propranolol complete absorption and urinary secretion. half life 4 hours. Atenolol and bisoprolol 50% faeces 50% renal excretion. Bisoprolol longest half life at 9-12 hours.
ADR’s - Bradycardia, dizziness, bronchoconstriction. dyspnoea, exacerbation of Raynauds, fatigue, GI disturbances, peripheral vasoconstriction, sexual dysfunction, hyper/hypo glycaemia.
Contraindications - Verapamil injection, bradycardia, asthma, hypotension, pheochromocytoma, Prinzmetals angina, 2nd/3rd degree heart block.
DDI’s - adrenaline, Adrenergic Neurone blockers, Alpha blockers, Amiodarone, Anti-arrhythmic, Diltazem, dobutamine, Flecainide, ??? Be careful of hypotension!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q
Doxazosin
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - alpha adrenoceptor antagonist
Mechanism of action - Antagonises the alpha-1 adrenoceptor on vascular smooth muscle to prevent vasoconstriction.
Indication - hypertension, benign prostatic hyperplasia
Pharmacokinetics - 65% absorbed. Hepatic metabolism, urinary elimination. Half like of 22 hours.
ADR’s - Anxiety, back pain, dyspnoea, fatigue, influenza like symptoms, paraesthesia, sleep disturbance, vertigo.
Contraindications - History of micturition syncope or postural hypotension.
DDI’s -Boceprevir (antiviral)
Tadalafil (antihypertensive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q
Lisinopril
Ramipril
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - ACE Inhibitors
Mechanism of action - competitive inhibitors of angiotensin converting enzyme to prevent the conversion of angiotensin I to angiotensin II - prevent RAAS activation
Indication - Hypertension, Hypertension, prophylaxis after MI, prevention in CHD,
Pharmacokinetics - Ramipril 50-60% absorption, Hepatic metabolism, also renal metabolism to active metabolite. Lisinopril - 25% absorption excreted unchanged by kidneys.
ADR’s - hypotension, dry cough, angioedema, renal failure, hyperkalaemia.
Contraindications- Pregnancy, Reno-vascular hypertension.
DDI’s - Alskiren (renin inhibitor), ARB, Been venom extracts, diuretics, Everolimus, Lithium, Potassium salts, sodium aurothiomalate (gold for RA), wasp venom extracts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q
Losartan
Candesartan 
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Angiotensin II Receptor Antagonists
Mechanism of action - Antagonise angiotensin II receptors to prevent the action of angiotensin II (and activation of RAAS)
Indication - Hypertension, LV Hypertrophy, heart failure, MI, prevention of CHD, Diabetic Nephropathy in type II diabetes.
Pharmacokinetics - Lorsatan - bioavailability of 33%, hepatic metabolism, 35% eliminated in urine, 60% faeces.
Candesartan - bioavailability 15%, eliminated unchanged in urine and faeces.
ADR’s - Hyperkalaemia, angioedema, hypotension
Contraindications - ?
DDI’s - rifampicin, ACE inhibitors, Alskiren, Ciclosporin, Diuretics, Lithium, potassium salts,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q
Glyceryl Trinitrate 
Isosorbide Mononitrate
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Nitrates
Mechanism of action - Converted to NO - activates guanylate cyclase pathway with produces cGMP which activates a series of protein kinase dependent reactions (dephosphorylate myosin light chain kinase) resulting in the relaxation of smooth muscle cells and vasodilation. Venodilation reduces preload on the heart and therefore myocardial oxygen demand.
Indication - angina pectoralis - prophylaxis and treatment, medical procedures, anal fissure.
Pharmacokinetics - isosorbide Mononitrate - 100% absorption, hepatic metabolism, excretion via urine. Half life 5 hours. GTN - as above half life is only 3 minutes.
ADR’s - Headache, nausea and vomiting, Dizziness, postural hypotension, tachycardia. Paradoxical bradycardia.
Contraindications - Aortic stenosis, Cardiac tamponade, cardiomyopathy, hypovolaemia, anaemia, Increased ICP.
DDI’s - Heparins, antihypertensive’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q
Amlodipine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - DHP calcium channel blockers.
Mechanism of action - Target L Type Calcium channels. Inhibits initial influx of calcium in smooth muscle so calcium induce calcium release is prevented and the muscle does not contract. Also work on myocardium and reduce contractility.
Indication - Hypertension, Angina
Pharmacokinetics -Almost completely absorbed. Hepatic metabolism, renal excretion. Half life 30-50 hours.
ADR’s - Postural hypotension, dizziness, confusion, SNS activation , tachycardia palpitations, flushing, sweating, headache, oedema, gingival hyperplasia.
Contraindications - cardiogenic shock, significant aortic stenosis, unstable angina
DDI’s - Grapefruit Juice, Lomitapide, Sildenafil, Simvastatin, St Johns Wort, Telaprevir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q
Diltiazem 
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Benzothiazepines Calcium channel blockers
Mechanism of action - Prevent calcium transport across the myocardial and smooth muscle. Prolongs action potential and effective refractory period. Peripheral vasodilation and a reduction in cardiac preload and myocardial contractility.
Indication- Angina
Pharmacokinetics
ADR’s -Bradycardia, Can worsen heart failure, dizziness, GI disturbances, hypotension, oedema
Contraindications - acute porphyria’s, LV failure, 2nd/3rd degree heart block, sever bradycardia, sick sinus syndrome
DDI’s - Amiodarone, Tacrolimus, Sirolimus, Simvastatin, Rifampacin, Oheyntoin, Lurasidone, Lomatapide, Ivabradine, Ibrtinab, Fosphenyoin, Dronedarone, Digoxin, Colchicine, Ciclsporine, Carbamazepine, Bosutinin, Beta blockers, Avanfil, Atazanir.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q
Verapamil 
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Phenylakylamines - Calcium channel blocker(Class IV antiarrhythmic agent)
Mechanism of action - depresses SA node and slows down AV node conduction. Impedes calcium transport across the membrane. Peripheral vasodilation reduction in cardiac preload.
Indication - hypertension, angina, cluster headache prophylaxis, SVT
Pharmacokinetics - 90% absorption, Hepatic metabolism, Urine and faeces elimination. Half life 3-7.5 hours.
ADR’s - Constipation, Bradycardia, reduction in cardiac contractility can worse heart failure. dizziness, flushing, headache, nausea, vomiting.
Contraindications - Acute porphyria’s, AF with accessory conducting pathways, bradycardia, cardiogenic shock, history of heart failure. 2nd/3rd degree heart block
DDI’s - Amiodarone, Theophylline, Sirolimus, Simvastatin, St. Johns Wort, Rifampacin, Oheyntoin, Lurasidone, Lomatapide, Lenalidomide, Ivabradine, Ibrtinab, Flecainide, Fingolimod, Everolimus Dronedarone, Disopyramide, Dabigatran, Digoxin, Colchicine, Ciclsporine, Carbamazepine, Bosutinin, Beta blockers, Avanfil, Atovastatin, GA, aminophylline.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q
Warfarin
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class -Anticoagulant (Coumarin)
Mechanism of action - Vitamin K antagonist. (Competitive inhibition) Vitamin K needed for addition of Gla domains on clotting factors. Gla domains required for localisation of clotting factors.
Indication - prevention of ischaemic stroke in AF, venous embolism, thromboembolism, prevention of clot formation in patients with prosthetic heart valve, TIA
Pharmacokinetics - Good GI absorption, slow onset, half life 48 hours, Heavily protein bound to albumin, Hepatic metabolism. Metabolites excreted in urine.
ADR’s - Bleeding, Intracranial haemorrhage, epistaxis, Gi loss, Teratogenic. Hepatic dysfunction, jaundice.
Contraindications - if

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q
Fondaparinux, apixiban, Edoxaban
Bivalirudin, Dabigatran, desirudin. 
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Anticoagulant
Mechanism of action - activates anti-thrombin III. Prevents the formation of a clot. Deactivates factor Xa, IIa, IXa.
Indication - When quick acting anticoagulation is required. DVT/PE. Cover. Thrombophylaxis.
Pharmacokinetics - Poor GI absorption given by injection. Removed by reticulo-endothelial system.Half life 1.5 hours. LMWH - given subcut.
ADR’s - Bruising/Bleeding, at injection sites, GI loss, epistaxis. Thrombocytopenia. Hyperkalaemia (inhibition of aldosterone secretion).
Contraindications -Bacterial endocarditis, after major trauma, haemophilia, peptic ulcer, recent cerebral haemorrhage, thrombocytopenia.
DDI’s - Aspirin, GTN spray,
Monitoring - aPPTq

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q
Protamine Sulphate
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Reversal of Heparin Therapy
Mechanism of action - Dissociates heparin from anti-thrombin III
Indication - Active bleeding from heparin.
Pharmacokinetics
ADR’s - allergy/Anaphylaxis, bradycardia, hyper/hypotension, pulmonary oedema.
Contraindications - allergy to fish
DDI’s - ?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q
Aspirin
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Anti-platelet and analgesic, anti-inflammatory, antipyretic.
Mechanism of action - Cyclooxygenase 1 and 2 inhibitor (irreversible) - prevents the production of prostaglandin - activate nociceptors in neurones at site of injury. Prevents production prostaglandin and thromboxane A2 in platelets - prevents aggregation.
Indication - Prevention in CHD, Acute injury, Inflammatory conditions, TIA, CVA, AF,
Pharmacokinetics - Good rapid absoption, highly bound to albumin, Metbaolised in liver excreted in urine.
ADR’s - Blood disorders, GI haemorrhage, Gi irritation, Skin reactions, tinnitus, bronchospasm.
Contraindications - Peptic ulcer disease, bleeding disorders, Reye’s syndrome, haemophilia, sever cardiac failure.
DDI’s - SSRI’s, Acetazoloamide, Coumarins, Methotrexate, NSAIDS, Phenindione, Venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q
Dipyridamole
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Anti-platelet
Mechanism of action - Phosphodiesterase inhibitor which blocks the uptake and metabolism of adenosine by RBS and vascular endothelial cells. Potentiate the anti-aggregating action of prostacyclin.
Indication - secondary prevention in stroke and TIA, Prosthetic valve. Myocardial imaging.
Pharmacokinetics - 70% absorbed, Metabolised in liver and excreted in bile. Half life of 40 minutes.
ADR’s - Positive inotropy and vasodilation - causes flushes and headaches. GI effects, Increased bleeding, bronchospasm. tachycardia.
Contraindications
DDI’s - Adenosine, coumarins, Pheninidone, Heparins, Clopidogrel, Antacids.

38
Q
Clopidogrel
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Anti-platelet
Mechanism of action Inhibition ADP dependent aggregation of platelets by blocking the receptor on platelet.
Indication - During PCI, ACS, Post MI (with aspirin)
Pharmacokinetics - prodrug so is metabolised by CY450 enzymes to active form. 50% absoption, urinary excretion.
ADR’s - Abdominal pain, bleeding disorders, diarrhoea, dyspepsia.
Contraindications - Active bleeding
DDI’s - Heparins, Coumarins, Carbamazepine, Chloramphenicol, Cimetidine, Ciprofloxacin, Erthromycin, esomeprazole, Etravirine, Fluoxetine, Fluvoxamine, Moclobemide, Phenindione, Rosuvastatin, anti-fungals, warfarin

39
Q
Alteplase
Reteplase
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Thrombolytic
Mechanism of action - Human tissue plasminogen activator - Activates plasminogen which then goes onto break up fibrin.
Indication - MI, Ischaemic Stroke, Acute PE.
Pharmacokinetics
ADR’s - allergies/anaphylaxis, bleeding, cerebral oedema, convulsions, rash, recurrent ischaemia, reperfusion arrhythmias.
Contraindications - Active pulmonary disease with cavitation, acute pancreatitis, aortic dissection, bacterial endocarditis, coagulation defects, history of cerebrovascular disease, recent surgery, oesophageal varices, recent symptoms of peptic ulcer disease.
DDI’s - Recent or concomitant use of drugs that increase bleeding.

40
Q
Simvastatin
Atorvastatin
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - HMG CoA Reductase Inhibitor
Mechanism of action - HMG CoA Reductase Inhibitor. Prevents the synthesis of hepatic cholesterol. Hepatic stores are depleted so liver cells express more LDL receptor and remove more LDL from the blood lowering plasma lipid.
Indication - hypercholesterolemia, reduce risk of CHD.
Pharmacokinetics - Simvastatin - 85% bioavailability, hepatic metabolism, small amount renally excreted mainly in faeces.
ADR’s - Hepatitis, jaundice, arthralgia, headache, hyperglycaemia, hypersensitivity, rhabdomyolysis.
Contraindications - ?
DDI’s - Statin + fibrate increases risk of myopathy. Macrolide antibiotics, imidazole and triazole antifungals. cyclosporine. Amiodarone, Amlodipine, Atanazir, bezafibrate, carbamazepine, grapefruit juice.

41
Q
Ezetimibe
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Lipid lowering therapy.
Mechanism of action - Cholesterol absorption inhibitor -
Indication - hypercholesterolemia, reduce risk of CHD. Adjunct therapy.
Pharmacokinetics - Metabolised in small intestine and liver, biliary and renal excretion. 22 hour half life.
ADR’s - fatigue, GI disturbances, headache, myalgia.
Contraindications - ?
DDI’s - ciclosporin, coumarins, fibrates, rosuvastatin.

42
Q
Bezafibrate
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Fibrates
Mechanism of action - Lowers serum triacylglycerol and increases HDL levels. Activation of PPARs. Increased expression of certain apoproteins and lipolipase and decreased expression of other apoproteins.
Indication - type III hyperlipidaemia.
Pharmacokinetics - completely absorbed after oral dose, widely bound to albumin, Hepatic metabolism and excretion in the urine. Half Life 1-2 hours.
ADR’s - GI Disturbances, abdominal distension, anorexia Lithiasis, myositis.
Contraindications - Existing gallbladder disease, severe hepatic/renal dysfunction. Hypoalbuminaemia.
DDI’s - ciclosporin, simvastatin

43
Q
Nictoinic acid 
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Niacin
Mechanism of action - Reduce LDL and most effective at raising HDL. Inhibits lipolysis in adipose tissue, this results in a reduction in VLDL and therefore LDL as there are no fatty acids to make cholesterol from in the liver.
Indication - Hypercholesteramia, familial hyperlipidaemias, reduce risk of CHD. Adjunct
Pharmacokinetics - Converted in the body to nicotinamide, Excreted in the urine.
ADR’s - intense cutaneous flush and pruritus - Administration of aspirin prior can reduce theses effects. Nausea and abdominal pain. Hyperuricaemia and gout.
Contraindications - Peptic ulcer disease, arterial bleeding, gout
DDI’s - statins

44
Q
Salbutamol
Terbutaline
Formoterol
Salmeterol
Class - action and onset?
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - B2 agonists
Fast onset/Short duration - Inhaled terbutaline, inhaled salbutamol.
Fast onset/Long duration - inhaled formoterol
Slow onset/Long duration - inhaled salmeterol.
Mechanism of action - Acts on Beta-2 receptors in the lungs, normally inhaled so has a selective effect.
Indication - Asthma, COPD - not necessarily reversible bronchoconstriction though. Uncomplicated premature labour.
Pharmacokinetics
ADR’s - Tachycardia, Palpitations, tremor, headache, peripheral vasodilation.
Contraindications - Severe pre-eclampsia
DDI’s - Atomoxetine, Digoxin, Methyldopa, Acetazolamide, Aminophylline, Corticosteroids, Loop and thiazide diuretics, Theophylline. Increased risk of hypokalaemia.

45
Q
Ipratropium Bromide
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Muscarinic Antagonist
Mechanism of action - blocks muscarinic receptors - no specificity for type. Reduces contractility
Indication - COPD - emphysema/chronic bronchitis. Acute bronchospasm, asthma, rhinorrhoea.
Pharmacokinetics - Inhalation, Renally eliminated. Half life 2-3 hours.
ADR’s - constipation, cough, diarrhoea, dry mouth, GI motility disorder, headache, angle-closure glaucoma, tachycardia.
Cautions - Bladder outflow obstruction, prostatic hyperplasia, susceptibility to angle-closure glaucoma.
DDI’s - Pasireotide - generally don’t apply though when inhaled.

46
Q
Tiotropium
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Muscarinic antagonist
Mechanism of action - blocks muscarinic receptors - no specificity for type. Reduces contractility causing bronchodilation.
Indication - COPD - Spiriva
Pharmacokinetics - bioavailability is 19.% after inhalation. Small amount of hepatic metabolism. Urinary excretion.
ADR’s - constipation, cough, diarrhoea, dry mouth, GI motility disorder, headache, angle-closure glaucoma, tachycardia.
Cautions - Cardiac arrhythmia in last 12 months, heart failure/MI in last 12 months. Bladder outflow obstruction, prostatic hyperplasia, susceptibility to angle-closure glaucoma.
DDI’s - do not generally apply because inhaled.

47
Q
Theophylline
Aminophylline
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Methylxanthines - aminophylline contains theophylline.
Mechanism of action - phosphodiesterase inhibitor, (phosphodiesterase is the enzyme responsible for breaking down cAMP in SM) adenosine receptor blocker, histone deacetylase activator. Diuretic, smooth muscle relaxant, bronchodilation, cardiac and CNS stimulant activities.
Indication - Asthma, COPD
Pharmacokinetics - Rapidly and completely absorbed. Hepatic metabolsims, 10% Renal excretion of unchanged theophylline. Half life 8 hours.
ADR’s - aarrhythmias, CNS stimulation, convulsions, diarrhoea, gastric irritation, headache, insomnia, tachycardia.
Caution - Cardaic arrhythmias/cardiac disease, epilepsy, hypertension etc…
DDI’s - LOTS Calcium channel blockers, cimetidine, ciprofloxacin, deferasirox, erythromycin, fluconazole, fluvoxamine, forphenytoin, interferon alfa, ketoconazole, norfloxacin, peginterferon alfa, phenobarbital, phenytoin, primidone, quinolones, rotionavir , verapamil.

48
Q
Beclomethasone dipropionate
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Corticosteroid
Mechanism of action - Inhalation steroid. Steroids cross the cell membrane and bind to cytoplasmic or nuclear receptors. Steroids inhibit leukocyte infiltration, interference in mediators - interleukin 1 and 6. Suppression of humoral immune responses.
Indication - Asthma, allergic rhinitis, oral ulceration (UC), eczema/psoriasis if other steroids have not worked.
Pharmacokinetics - Metabolism by tissues, Excreted in faeces. Half life 2.8hours.
ADR’s - Paradoxical bronchospasm, adrenal crises, aggression, anxiety, Cushing’s syndrome, depression, reduced bone mineral density. Weight gain, oedema, glucose intolerance.
Contraindications - those with live viruses/systemic infections,
DDI’s - Inhaled so interactions don’t generally apply.

49
Q
Budesonide
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Corticosteroid
Mechanism of action - Glucocorticoid with weak mineralocorticoid action. Binds to glucocorticoid receptor with higher affinity than cortisol or prednisolone. Inhibitory effects against, mast cells, eosinophils, neutrophils, macrophages, lymphocytes, and mediators such as histamine, eicosanoids, leukotrienes and cytokines.
Indication - Asthma, skin disorders, allergic rhinitis, UC, Nasal Polyps
Pharmacokinetics -Undergoes significant first pass metabolism. Metabolites are not active. Excreted in urine and faeces. Half life 2-3.6 hours.
ADR’s - Paradoxical bronchospasm, adrenal crises, aggression, anxiety, Cushing’s syndrome, depression, reduced bone mineral density. Weight gain, oedema, glucose intolerance.
Contraindications - Live vaccines, systemic infection.
DDI’s - Inhaled no interactions as not systemically absorbed.

50
Q
Fluticasone
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Corticosteroid
Mechanism of action - Highly retained in respiratory tissue, has a prolonged action. Inhibitory effects against, mast cells, eosinophils, neutrophils, macrophages, lymphocytes, and mediators such as histamine, eicosanoids, leukotrienes and cytokines.
Indication - Asthma, COPD, allergic rhinitis, nasal polyps, skin conditions,
Pharmacokinetics - Extensive first pass metabolism, eliminated in the faeces, 17-24 hour half life.
ADR’s - arthralgia, dyspepsia, Glaucoma, adrenal crises, aggression, anxiety, Cushing’s syndrome, depression, reduced bone mineral density. Weight gain, oedema, glucose intolerance.
Contraindications - Acne, plaque psoriasis, untreated bacterial, fungal or viral skin lesions.
DDI’s - Inhaled no interactions as not systemically absorbed

51
Q
Prednisolone
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Corticosteroid
Mechanism of action
Indication - COPD, Croup, Asthma, Local treatment of inflammation, suppression of inflammatory and allergic disorders - UC/Crohn’s, eczema, Myasthenia gravis….
Pharmacokinetics - Readily absorbed, Excreted in urine. 2 to 3 hour half life.
ADR’s - Amenorrhoea, Cushing’s syndrome, dyspepsia, glaucoma, hirsutism, lipid dysfunction, impaired healing, increased appetite, leucocytosis, muscle weakness, thromboembolism, weight gain, water retention.
Contraindications - Avoid live virus vaccines, systemic infection,
DDI’s - Ciclosporin, Aldesleukin, Amphotericin, Carbamazepine, coumarins, Fosphenytoin, Phenobarbital, Phenytoin, Primidone, Rifamycins, Ritonavir, Vaccines

52
Q
Montelukast
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Leukotriene Receptor Antagonist
Mechanism of action - Blocks the leukotriene receptor which prevents airway oedema, smooth muscle contraction and enhanced secretion of thick viscous mucous.
Indication - Asthma, seasonal allergic rhinitis.
Pharmacokinetics - rapidly absorbed 64% bioavailability, hepatic metabolism, excreted exclusively by the bile. Half life 2.5-5.5 hours.
ADR’s - Abdo. pain, headache, hyperkinesia, thirst,
Contraindications -?
DDI’s - Gemifibrozil, Phenobarbital, Primidone

53
Q
Diazepam
Lorazepam
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Benzodiazepine - Anxiolytic, Sedative, Anticonvulsant
Mechanism of action - Bind non-specifically to benzodiazepine receptors which mediate sleep, muscle relaxation, anticonvulsant activity, motor coordination and memory. Benzodiazepine receptors are coupled with GABA receptors, by increasing the affinity for GABA to the GABA receptor this increases activation of GABA channels resulting in Cl- influx caused hyperpolarisation of the cell preventing further excitation.
Indication - Anxiety disorders, short term management of insomnia, Muscle spasm, tetanus. sedative/premedicant/anticonvulsant in alcohol withdrawal syndrome. Status epilepticus
Pharmacokinetics -Near complete absorption, Hepatic metabolism, excreted renally. 1-2 day half life. Lorazepam - 2 hour half life
ADR’s - Drowsiness, dizziness, psychomotor impairment, dry mouth, blurred vision, GI upset, ataxia, headache, hypotension. Amnesia. Can get tolerance and dependence.
Contraindications - acute pulmonary insufficiency, neuromuscular respiratory weakness, sleep apnoea, unstable myasthenia gravis neonates, obsessional states
DDI’s - fluconazole, Ritonavis, Voriconazole, clozapine, Olanzapine, Sodium oxybate.

54
Q
Haloperidol
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Typical Anti-psychotic
Mechanism of action - Depress CNS at subcortical level of brain, midbrain and brain stem reticular formation. Strong anti-dopaminergic and weak central anticholinergic activity.
Indication - Nausea and Vomiting, Schizophrenia, Psychoses, mania, Tourette’s, Tics,
Pharmacokinetics - 60% absorption, Hepatic metabolism, half life 3 weeks,
ADR’s - Neuroleptic malignant syndrome, angle-closure glaucoma, agitation, confusion, constipation, diabetes, extrapyramidal symptoms, Parkinsonion symptoms, purplish pigmentation. weight gain.
Contraindications - Bradycardia, CNS depression, lesions of basal ganglia, Parkinson’s disease, phaeochromocytoma, QT interval prolongation.
DDI’s - Increased risk of toxicity with myelosupressive drugs, Avoid concomitant administration with drugs that prolong QT, Amiodarone, TCA antidepressants, arsenic trioxide, Bosutinib, citalopram, clozapine, disopyramide, fluoxetine, quinine, rifampicin.

55
Q
Chlorpromazine 
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Typical Antipsychotic
Mechanism of action - Antagonist of postsynaptic dopaminergic, serotonergic, histaminergic, muscarinic, alpha 1 and 2 receptors. This leads to a wide range of useful and adverse reactions. Anxiolytic, anti-depressive, anti-aggressive. sedation, antiemesis,
Indication - Nausea and Vomiting, Schizophrenia, Psychoses, mania,
Pharmacokinetics - Rapidly absorbed from GI tract. Extensively metabolised by liver and kidney. Renal excretion.
ADR’s - Neuroleptic malignant syndrome, attenuation of extra-pyramidal side effects, weight gain, hypotension, sedation, ejaculation difficulties, vertigo, hyper salivation, incontinence, dry mouth. blurred vision, sinus tachycardia, ECG changes.
Contraindications - Parkinson’s, CNS Depression, comatose states, hypothyroidism, phaeochromocytoma.
DDI’s - Increased risk of toxicity with myelosupressive drugs, Amiodarone, Propanolol, Telithromycin, Vandetanib,

56
Q
Olanzopine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Atypical Antipsychotic
Mechanism of action -
Indication - Positive and Negative symptoms of Schizophrenia, acute mania with bipolar, psychotic symptoms in dementia. Binds to alpha 1, dopamine (most important action in frontal cortex - limbic system), histamine H1, muscarinic and serotonin type 2 receptors.
Pharmacokinetics - 60% bioavailability, Hepatic Metabolism, Urinary excretion. Half life 21 to 54 hours.
ADR’s - Neuroleptic malignant syndrome, arthralgia, hypercholesterolemia, hypertriglyceridemia, increased appetite, malaise, oedema. Weight gain. Increased risk of developing T2DM.
Contraindications -IM - MI, bradycardia, recent heart surgery, severe hypotension, sick sinus syndrome, unstable angina.
DDI’s - Increased risk of toxicity with myelosupressive drugs. Benzodiazepines, Fluvoxamine, Sodium Valporate, Valporic Acid.

57
Q
Citalopram
Fluoxetine
Sertraline 
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Selective Serotonin Re-uptake Inhibitors
Mechanism of action - Prevents re-uptake of serotonin in the synapse by blocking the action of the re-uptake channels on the pre-synaptic membrane. This means more acts on post-synaptic receptors.
Indication - Depression, Panic Disorder, bulimia nervosa, OCD
Pharmacokinetics - Bioavailability 80%, hepatic metabolism, urine and faeces elimination. 35 hour half life.
ADR’s - Abdominal pain, constipation, diarrhoea, dyspepsia, nausea, vomiting.
Contraindications - poorly controlled epilepsy, Manic phase, QT Interval prolongation.
DDI’s - avoid concomitant administration of drugs that prolong QT Interval, Amiodarone, TCA’s, Chloroquine, Disopyramide, Dronedarone, Eythromycin, Haloperidol, MAOIs, Mizolastine, Mocolobemide, Moxifloxacin, Phenothiazines, Pimozide, Quinine etc…..

58
Q
Imipramine 
Lofepramine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Tricyclic Antidepressants
Mechanism of action - Inhibits serotonin and noradrenaline reuptake. Also histamine, alpha 1 adrenergic and muscarinic receptor blocker.
Indication - Depression, Panic disorders, eating disorders, Nocturnal enuresis.
Pharmacokinetics - may take 2-4 weeks to take effect, bioavailability is 43%, hepatic metabolism, mainly renal elimination.
ADR’s - fatigue, flushing headache, palpitation, restlessness, sedation and impairments of psychomotor performance, lower of seizure thresholds, reduction in glandular secretions, tachycardia, postural hypotension, constipation. Lofepramine - Agitation; anxiety; confusion; dizziness; irritability; paraesthesia; postural hypotension; sleep disturbances
Contraindications - Acute porphyria’s, immediate recovery after MI, arrhythmia, manic phase of bipolar, heart block.
DDI’s - Cimetidine, Diltiazem, Labetalol, Propranolol, Thyroid hormones, verapamil.

59
Q
Cyclizine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - H1 histamine antagonist - Anti-emetic
Mechanism of action - Block the histamine receptors in the vomiting centre and reduce activity along these pathways. Also has anti-cholinergic effects.
Indication- acute Nausea, Vomiting, vertigo, motion sickness, labyrinth disorders.
Pharmacokinetics - Half life 20 hours.
ADR’s - Drowsiness, (anti-cholinergic side effects) confusion, convulsions, tremor, sleep disturbances.
Contraindications - acute porphyria’s, neonate
DDI’s - Opioid analgesics

60
Q
Domperidone
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - D2 antagonist
Mechanism of action - Acts on the postrema on the floor of the 4th ventricle (location of the vomiting centre) and stomach to increase the rate of gastric emptying.
Indication - Acute Nausea and Vomiting
Pharmacokinetics - Oral or PR route - does not cross blood brain barrier. Hepatic metabolism. Half life 7 hours.
ADR’s - Drowsiness, dry mouth, malaise, stimulates prolactin release can get galactorrhoea, anxiety, breast pain, increased libido, diarrhoea, QT interval prolongation, gynecomastia, Dystonia.
Contraindications - Cardiac disease, GI haemorrhage, Mechanical obstruction, mechanical perforation, predisposition to cardiac conduction disorders.
DDI’s - Drugs that prolong QT interval. drugs that at potent CYP3A4 inhibitors. some anti-malarias, some anti-virals (Hep C and HIV), clarithromycin and telithromomycin, ketoconazole, voriconazole,

61
Q
Ondansetron
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - 5HT antagonist
Mechanism of action - Affects the postrema on the floor of the 4th ventricle (vomiting centre/) and the CTZ. Blocks serotonin receptors peripherally - vagal afferents in the GI tract. Effect can be enhanced by a single dose of corticosteroid.
Indication - Nausea, Vomiting due to radiation/Chemo/Post op.
Pharmacokinetics - IV/IM or oral, well absorbed limited first pass metabolism, hepatic metabolism, half life 5.7hours.
ADR’s - Headaches, constipation, flushing, arrhythmias, bradycardia, chest pain, hypotension.
Contraindications - Congenital Long QT syndrome
DDI’s - Caution with drugs that prolong QT, Apomorphine, Vanderanibp

62
Q
Paracetamol
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Analgesic and antipyretic
Mechanism of action - Inhibits COX 1,2,3 in the CNS only, not peripherally. No effect on platelets or inflammatory mechanism.
Indication - Mild to moderate, pain relief, relief of fever,
Pharmacokinetics - Rapid and almost complete absoption, hepatic metabolism, Renal elimination half life 1 to 4 hours.
ADR’s - Malaise, skin reactions, stevens Johnson syndrome, blood disorders, luecopenia, neutropenia, thrombocytopenia.
Contraindications - ?
DDI’s - No Red flags. Carbamezapine, Colestryamine, Coumarins, Fosphenytoin, Imatinib, Ketoconazole, Lixisenatide, Metoclopramide, Phenobarbital, phenytoin, primidone.

63
Q
Morphine
Tramadol
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Mu-opioid receptor agonist
Mechanism of action - Agonises the mu opioid receptor which causes outward efflux of K+ this reduces the excitability of the neurone and hyperpolarises the cell. This means CA2+ entry and neurotransmitter release is less likely.
Indication - Severe Pain
Pharmacokinetics
ADR’s - constipation, respiratory depression, nausea, euphoria/confusion, vomiting, drowsiness, miosis, hypotension. Tolerance and dependence.
Contraindications - Acute respiratory depression, comatose patients, head injury, raised ICP, risk of paralytic ileus, bradycardia,
DDI’s - Baclofen, Buprenorphine, Esmolol, Gabapentin, Pentazocine, Rifampicin, Ritonavir.

64
Q
Codeine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - mu opioid receptor agonist.
Mechanism of action - Mu receptors are coupled to GPCRs. Inhibition of cAMP production. Release of neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline are inhibited. Less affinity for receptor than morphone
Indication - moderate pain, acute diarrhoea, suppression of cough
Pharmacokinetics -well absorbed bioavailability of 90%, hepatic metabolism, codeine is a prodrug and is converted to morphine. Eliminated renally.
ADR’s - constipation, respiratory depression, nausea, euphoria/confusion, vomiting, drowsiness, miosis, hypotension. Tolerance and dependence.
Contraindications - Acute respiratory depression, comatose patients, head injury, raised ICP, risk of paralytic ileus, bradycardia,
DDI’s -Anti-muscarinics, Rifampicin, antihistamines, MAOIs, Moclobemide, Nalmefene, Sodium Oxybate.

65
Q
Carbamazepine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - AED
Mechanism of action - Blocking use dependent sodium channels to prevent the repeated stimulation of neurones.
Indication - Primary generalised tonic clonic seizures and focal and secondary generalised tonic clonic seizures. Pain in trigeminal neuralgia.
Pharmacokinetics - Hepatic metabolism, urinary and faeces elimination. Strong inducer of CYP450, effects its own metabolism so after repeated use half life decreases.
ADR’s - Allergic skin rashes, dizziness, drowsiness, ataxia, motor disturbance, numbness and tingling, Variation in BP. Eosinophilia, leucopenia, thrombocytopenia, urticaria, oedema.
Contraindications - Acute Porphyrias, AV conduction abnormalities, history of bone marrow depression.
DDI’s - EVERYTHING!!!!! IT HATES MOST DRUGS
Monitoring, dose needs to be adjusted as half life decreases.

66
Q
Lamotrigine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - AED
Mechanism of action - Prolongs the voltage gated sodium channel inactivation state which doesn’t allow the release of teh excitatory neurotransmitter glutamate.
Indication - Partial seizures, generalised tonic clonic and absence seizures. Bipolar disorder and depression.
Pharmacokinetics - Well absorbed, linear 24 hours, not CYP metabolism.
ADR’s - Dizziness, Ataxia, Somnolence, nausea, mild-serious skin rashes, diplopia, agitation, aggression.
Contraindications -?
DDI’s - Oral Contraceptives, Rifampicin, Sodium Valproate, Valproic Acid.

67
Q
Phenytoin
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - AED
Mechanism of action - Primary site of action is the motor cortex. Acts on sodium channels by promoting sodium efflux from neurones
Indication - Generalised tonic-clonic, all partial seizures, not absence seizures. Status Epilepticus.
Pharmacokinetics - Well absorbed but 90% bound in plasma, CYP450 inducer. Variable half life from 6 to 24 hours.
ADR’s - Dizziness, ataxia, headache, nystagmus, nervousness, gingival hyperplasia, rashes, stevens johnson syndrome. Anorexia, insomnia, rash,
Contraindications- Acure Porphyrias, 2nd and 3 rd degree heart block, SA block, sinus bradycardia,
DDI’s - Valproate, NSAIDs, Oral contraceptives, cimetidine, etc…… Also lots.
Monitoring - close monitoring of free concentration in the plasma.

68
Q
Sodium Valporate
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - AED
Mechanism of action - Becomes valproate ion in GI tract and binds to and inhibits GABA transaminase. By inhibiting enzymes that break down GABA there is more GABA present in the brain.
Indication - All forms of epilepsy, Bipolar disorder.
Pharmacokinetics - Rapid absorption, metabolised by the liver,
ADR’s- Aggression, anaemia, convulsion, diarrhoea, extrapyridamal disorders, menstrual disorders, weight gain, memory impairment. Teratogenic risk
Contraindications - Family history of severe hepatic dysfunction, known mitochondrial disorders,
DDI’s - Lots - Carbapenems, Cimetidine, Lamotrigine, Olanzapine, Pivmecillinam, Sodium oxybate

69
Q
Benzylpenicillin
Amoxicillin
Flucloxacillin
Co-amoxiclav
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Penicillin- Beta lactam antibiotic
Mechanism of action - Inhibition of cell wall synthesis - poor penetration into CSF. Inhibit cross link formation in the bacterial cell wall. Beta lactam ring of the penicillin binds to the enzyme which normally forms cross links. Therefore there is more degradation than formation so the cell wall is broken down. Water enters and causes lysis. (Co-amoxiclav - plus clauvanic acid a beta lactamase inhibitor)
Indication - Mild to moderate susceptible infections, staphylococcal, streptococcal infections. Throat infections, otitis media, cellulitis, pneumonia. Amoxicillin - H.Pylori eradication with metronidazole and omeprazole.
Pharmacokinetics - Hepatic metabolism, renal elimination.
ADR’s - Anaphylaxis, angioedema, diarrhoea, fever, joint pains, rashers, serum sickness like reaction, urticaria.
Contraindications - Allergy, Species resistant to penicillins,
DDI’s - No severe interactions: Coumarins, Methotrexate, Phenindione, Sulfinpyrazone, Tetracyclines.

70
Q
Cefaclor
Cefotaxime
Aztreonam
Ceftiraxone
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Cephalosporins - Beta lactam antibiotic
Mechanism of action - Inhibition of cell wall synthesis - poor penetration into CSF. (Unless ceftriaxone) Inhibit cross link formation in the bacterial cell wall. Beta lactam ring of the penicillin binds to the enzyme which normally forms cross links. Therefore there is more degradation than formation so the cell wall is broken down.
Indication - Gram positive and gram negative bacteria, Pseudomonas aeruginosa, Haemophilus influenzae, and Neisseria meningitis, Gonorrhoea (not cefaclor)
Pharmacokinetics - Mostly excreted unchanged in urine within 8 hours. Greater proportion within the first 2 hours.
ADR’s - antibiotic associated colitis, abdo. discomfort, allergic reaction, headache, pruritus, sleep disturbances, stevens-johnson syndrome, thrombocytopenia,
Contraindications - ?
DDI’s - Antacids, Teriflunomide, aminoglycosides (nephrotoxicity) Coumarins

71
Q
Tetracycline 
Doxycycline
Oxytetracycline
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Tetracyclines
Mechanism of action - Binds reversibly to the bacterial 30S ribosomal subunit to block tRNA from binding to the A site, which prevents protein synthesis.
Indication- Chlamydiae spp., Lyme Disease, Acne, rickettsia, syphillis, PID
Pharmacokinetics - 60-80% orally, not metabolised, concentrated in the liver in the bile and excreted in the urine and faeces at high concentrations. Half life 6-12 hours.
ADR’s - Anaphylaxis, hepatoxicity, pancreatitis, pericarditis, stevens-johnson syndrome, antibiotic associated colitis, benign intracranial hypertension.
Contraindications - Children under 12 yrs of age (deposition in growing bone and teeth by binding to teeth and staining them)
DDI’s - Antacids, aluminium, milk, Calcium, iron, magnesium and zinc salts decrease the absorption of tetracyclines. Coumarins, Phenindione, Retinoids,

72
Q
Gentamicin
Neomycin
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Aminoglycosides
Mechanism of action - Binds irreversibly to the 30s ribosomal subunit. Causes misreading of tRNA,
Indication -P. aeruginosa, (tobramycin C.F patients) Proteus, E. Coli, Klebsiella, Citrobacter, Staphylococcus, enterobacter, Lots!
Pharmacokinetics - Poorly absorbed orally can be given topically or injection,
ADR’s - Nephrotoxic, Ototoxic , Antibiotic associated colitis, electrolyte disturbances,
Contraindications - Myasthenia Gravis (aminoglycosides may impair neuromuscular transmission)
DDI’s - Don’t administer with other ototoxic drugs. Ciclosporin, Loop Diuretics, Muscle relaxants, Neostigmine, platinum compounds, pyridostigmine, suxamethonium, Tacrolimus, Vacomycin.

73
Q
Erythromycin 
Clarithromycin
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Macrolides
Mechanism of action - Inhibits peptidyltransferase from adding new amino acids to the existing peptide.
Indication - Patients with penicillin allergy, lyme disease, early syphillis, whopping cough, chronic prostatitis, diphtheria, post splenectomy in penicillin allergy, Acne,
Pharmacokinetics
ADR’s - Abdominal discomfort, diarrhoea, nausea, vomiting, cholestatic jaundice, hepatotoxicity, rash,
Contraindications
DDI’s - Concomitant use with drugs that prolong Q-T interval. Aminophylline, Avanafil, Bosutinib, Calcium channel blockers, Carbamazepine, ciclosporin, cilostazol, citalopram, clopidofrel, clozapine, colchicine coumarins, disopyramide, eletriptan, ergo alkaloids, everloimus, Ibrutinib, Ivacaftor, Lomitpide, Lurasidone, Midazolam, Mizolastine, Quetiapine, Rigabutin, Rilpivirine, Simeprevir, Simvastatin, Sirolimus, Tacrolimus, Theophylline, Vinblastine,

74
Q
Vancomycin
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Glycopeptide
Mechanism of action - prevents incorporation of certain subunits in the peptidoglycan cell wall. Not active against Gram -ve
Indication - MRSA, C. difficile infection, peritonitis associated with perennial dialysis.
Pharmacokinetics - Oral absorption poor. Urinary excretion.
ADR’s - Ototoxic, nephrotoxic, blood disorders, neutropenia, renal failure, thrombocytopenia
Contraindications - Avoid if history of deafness and elderly
DDI’s - Aminoglycosides, ciclosporin, loop diuretics, suxamethonium.

75
Q
Ethambutol
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Anti-tubercular agent
Mechanism of action - Inhibits enzymes needed for cell wall synthesis.
Indication - TB (6 months)
Pharmacokinetics - 75 to 80% absorbed orally. Hepatic metabolism, elimination by urine and faeces.
ADR’s - Pruritus, Rash, Thrombocytopenia, urticaria, loss of visual acuity, colour blindness, optic neuritis.
Contraindications - Optic neuritis, poor vision
DDI’s - Delamanid

76
Q
Isoniazid
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Anti-bacterial
Mechanism of action - Inhibits the synthesis of mycoloic acids needed for cell wall synthesis
Indication TB 6 months, Prevention of TB for those susceptible close contacts.
Pharmacokinetics-Prodru which must be activated by bacterial catalase. Some first past metabolism, reduced absorption with food. Hepatic metabolism. Fast half life. Renal excretion.
ADR’s - Peripheral neuropathy, hepatitis, psychotic episodes.
Contraindications - Drug induced liver disease.
DDI’s

77
Q
Pyrazinamide
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI'sv
A

Class - Anti-tubercular agent
Mechanism of action - Purazinamide is converted to pyrazinoic acid in the bacterium and the acid accumulates within the cell. This inhibits fatty acid synthesis, disrupts membrane potential, interferes with energy production and can inhibit translation.
Indication - TB 6 months
Pharmacokinetics - Rapidly and well absorbed from GI tract. Hepatic metabolism, half life 9-10 hours,
ADR’s - Hepatotoxicity, anorexia, arthralgia, fever, jaundice, thrombocytopenia.
Contraindications - acute attack of gout
DDI’s - Sulfinpyrazone

78
Q
Rifampicin
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Antibiotic
Mechanism of action - inhibits bacterial RNA polymerase.
Indication - TB (6 months), Legionnaires disease, endocarditis, prevention of TB for close contacts,
Pharmacokinetics - Well absorbed from GI tract, hepatic metabolism, excreted in bile.
ADR’s - Acute renal failure, Antibiotic associated colitis, DIC, GI symptoms, Jaundice, leucopenia, Rashers, orange-red saliva/urine, Myopathy, menstrual disturbance.
Contraindications - Acute porphyria, jaundice,
DDI’s - Induces Hepatic enzymes, Hep C and HIV antivirals, Abiraterone, Apixaban, Atovaquone, Cannabis extract, ciclosporin,dabigatran, Diltiazem, Fluconazole, Haloperidol, Imatinib, Isoniazid, Ketoconazole, Lamotrigine, Nifedipine, Quinine, Tacrolimus, Ticagrelor, Verapamil

79
Q
Amantadine 
Rimantadine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - M2 channel inhibitors
Mechanism of action - Inhibits the M2 channels on Influenza A to prevent uncoating of the viral protein. Resistance is high.
Indication - Influenza A
Pharmacokinetics - Excreted by renal system.
ADR’s
Contraindications
DDI’s

80
Q
Zanamivir (inhaled)
Oseltamivir
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Neuraminidase Inhibitors
Mechanism of action -Inhibits neuromanidase which alters virus replication and release.
Indication - Prevention and Treatment of Influenza,
Pharmacokinetics - BIoavailabilty 75%, eliminated in urine. Half life 1 to 3 hours.
ADR’s - Abdominal pain, dyspepsia, headache, nausea, vomitting, arrhthmia, convulsions, eczema, rash.
Contraindications
DDI’s

81
Q
Flucanazole
Clotrimazole
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - anti-fungal
Mechanism of action - Clotrimazole - topical application, inhibits the synthesis of a key membrane component, ergosterol, which increases the cellular permeability.
Indication - Fungal infections, otitis externa, skin infections, vaginal candidiasis, prevention of fungal infection in immunocompromised patients.
Pharmacokinetics
ADR’s - local irritation, local sensitivity
Clotrimazole - abdominal discomfort, diarrhoea, flatulence, headache, nausea, rash.
Caution - Clotrimazole - avoid contact with eyes and mucosal membranes. Fluconazole - can be taken oral/Iv - Acute porphyria.
DDI’s fluconazole - Lots - drugs that cause hepatic impairment.

82
Q
Nyastatin 
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Anti-fungal
Mechanism of action - topical use, binds to ergosterol in the cell membrane which causes pores to form and the cell contents leak out.
Indication - Oral and perioral fungal infections,
ADR’s - local irritation, local sensitisation burning sensation, erythema, hypersensitivity reaction, itching, - with oral topical use, nausea,
Caution - contact with eyes and mucous membranes should be avoided.

83
Q
Metronidazole
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - anti-protozoal and antibiotic
Mechanism of action - Enters cell as prodrug, it is reduced within the ell to its active form where it covalently binds to DNA disrupting its helical structure inhibiting DNA synthesis and causing cell death.
Indication - Anaerobic infections, c.difficile associated colitis,
Helicobacter eradication, Fistulating crohn’s disease, lef ulcers and pressure sores, bacterial vaginosis, PID, acute ulcerative gingivitis, acute oral infections, surgical prophylaxis, urogenital trichomoniasis, Giardiasis, Tetanus.
Pharmacokinetics - prodrug, well absorbed, half life 6-8 hours, Hepatic metabolism.
ADR’s - Anorexia, aseptic meningitis, GI disturbances, nausea, optic neuropathy, taste disturbances, vomiting,
Contraindications
DDI’s - Alcohol, Busulfan, Coumarins,

84
Q
Aciclovir
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
85
Q
Amphotericin
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - anti-fungal
Mechanism of action
Indication- Aspergillus spp. Systemic fungal infections. Binds to ergosterol in the cell membrane and creates a pore which the cellular contents leak out of.
Pharmacokinetics - Renal metabolism. Half life of 15 days.
ADR’s - Abdominal pain, abnormal liver function, blood disorders, CVS effects, chest pain. diarrhoea, electrokyte disturbances, hypokalamia nausea, rash, thrombocytopenia.
Contraindications - Anaphylaxis
DDI’s - Corticosteroids, Cardiac glycosides, ciclosporin, Tacrolimus,

86
Q
Chloroquine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Anti-malaira
Mechanism of action - Causes heam to build up within the RBC. Haem that has not been crystallised by the parasite is toxic to it.
Indication - Malaria prophylaxis and treatment (non-falciparum), RA, SLE,
Pharmacokinetics - completely absorbed from GI tract, hepatic metabolism, excretion slowly in the urine. Half life 1-2 months.
ADR’s - GI disturbances, headache, pruritis, rashes, skin reactions.
Contraindications
DDI’s - Avoid concurrent therapy with hepatotoxic drugs. Amiodarone, Ciclosporin, Citalopram, Digoxin,

87
Q
Venlafaxine 
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - SNRIs (serotonin/norepinephrine re-uptake inhibitors)
Mechanism of action - Potent inhibitor of serotonin reuptake and at medium to higher doses also inhibits norepinephrine reuptake.
Indication - Major Depression, Generalised and Social anxiety disorder.
Pharmacokinetics - Half life approx 11 hours,
ADR’s - Nausea, vomiting, headache, sexual dysfunction, dizziness, insomnia, sedation, constipation, abnormal dreams. At high doses increased HR and hypertension.
Contraindications - conditions associated with a high risk of cardiac arrhythmia, uncontrolled hypertension
DDI’s - Amiodarone, Aspirin, Dapoxetine, Erythromycin, MAOI’s, Moxifloxacin, NSAIDs, selegeline, Sotalol, Warfarin.

88
Q
Risperidone
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Atypical Anti-psychotic
Mechanism of action - D2 antagonist, alpha 1 adrenoceptors, H1 receptor antagonist. 5HT receptor antagonist.
Indication - Schizophrenia, Acute and chronic psychosis, mania, persistent aggression in patients with alzheimers.
Pharmacokinetics - Well absorbed, 70% oral bioavailability, Hepatic metabolism, 20-24 hour half life.
ADR’s - Neuroleptic malignant syndrome, Angle-closure glaucoma, agitation, agranulocytosis, extrapyradmial symptoms. hyperprolactinaemia, sexual dysfunction, weight gain, tardive dyskensia.
Contraindications - no IM use in children. Avoid in acute porphyries, dehydration, Lewy body dementia, prolactin dependent tumours,
DDI’s - TCA’s, Antipsychotics, Clozapine, Lithium, Mefloquine, Quinine, Sotalol.

89
Q
Quetiapine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Atypical antipsychotic
Mechanism of action -D2 antagonist, alpha 1 adrenoceptors, H1 receptor antagonist. 5HT receptor antagonist. (Less likely to causes extra-pyramidal side effects)
Indication - Schizophrenia, mania and depression in bipolar disorder, adjunctive treatment in major depression.
Pharmacokinetics - Hepatic Metabolism, Half life 6 hours.
ADR’s -Neuroleptic malignant syndrome, Precipitation of angle closure glaucoma, agitation, insomnia, parkinsonian symptoms, sexual dysfunction, weight gain, GI disturbance etc.
Contraindications - cerebrovascular disease, elderly, Parkinson’s, prostatic hypertrophy,
DDI’s - Antifungals, HIV and Hep C drugs, Clarithromycin, Erythromycin, Grapefruit juice,

90
Q
Clozapine
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Atypical Antipsychotic
Mechanism of action- D1, D2, 5Ht, alpha 1 adrenoceptors and muscarinic antagonist. Other antipsychotics must be tapered off first.
Indication - Schizophrenia in those unresponsive or intolerant to conventional antipsychotics. Psychosis in Parkinson’s disease.
Pharmacokinetics
ADR’s - neuroleptic malignant syndrome, anorexia, constipation, hyper salivation, malaise, speech disorders, urinary incontinence. agranulocytosis, circulatory collapse, cardiomyopathy, hepatitis, pancreatitis.
Contraindications - Alcoholic and toxic psychoses, bone-marrow disorders, history of agranulocytosis, history of circulatory collapse, history of neutropenia, severe CNS depression, uncontrolled epilepsy.Age over 60. prostatic hypertrophy.
DDI’s Benzodiazepines, Carbamezapine, Chloramphenicol, cytotoxic, erythromycin, Flecainide, fluoxetine, flupentixol, fluphenazine, Haloperidol. MAOI’s, Paroxetine, Penicilline, Pipotiazine, Risperidone, Some HIV and Hep C antivirals. Sertraline, Sulfonamides, Zuclopenthixol.
Monitoring Required - Can cause agranulocytosis - can only get drug from mental health pharmacy.

91
Q
Lithium Carbonate
Class
Mechanism of action
Indication
Pharmacokinetics
ADR's
Contraindications
DDI's
A

Class - Anti-mania drug
Mechanism of action - Not currently known, may act on glutamate receptors to stabilise the amount of glutamate so that it doesn’t get too low or too high.
Indication - Treatment and Prophylaxis for: mania, bipolar disorder, recurrent depression, aggressive or self harming behaviour.
Pharmacokinetics - Very narrow therapeutic window, Slow release preparations available so can be given once daily.
ADR’s - Memory Problems, Thirst, polyuria, tremor, drowsiness, weight gain, hypothyroidism, hair loss, rashes.
Contraindications - Addison’s disease, cardiac insufficiency, dehydration, family/personal history of Brigade syndrome, low sodium diet, hypothyroidism.
DDI’s - Drugs which may lower seizure threshold, prolong QT interval, Lithium toxicity made worse by sodium depletion so careful use with diuretics. EVERYTHING